General anaesthesia for surgery requires
Rationale:
General anaesthesia for surgery requires all of the above: unconsciousness, analgesia, and suppression of visceral reflexes.
D: This option comprehensively encompasses the essential components of general anaesthesia. Unconsciousness ensures the patient is unaware, analgesia prevents pain perception, and suppression of visceral reflexes avoids involuntary bodily responses during surgery, collectively ensuring safety and comfort.
A: Unconsciousness alone does not address pain control or reflex suppression, both crucial for effective surgical anaesthesia and patient stability.
B: Analgesia solely manages pain but lacks unconsciousness and reflex inhibition, which are vital to prevent awareness and motor responses during surgery.
C: Suppression of visceral reflexes focuses on reflex control but fails to provide unconsciousness and analgesia, necessary for patient immobility and pain relief.
The D3 receptors are preferentially present in
Rationale:
D3 receptors are preferentially present in negative inotropy. This is because D3 receptors modulate cardiac contractility by decreasing myocardial force generation, leading to negative inotropic effects. Their activation influences calcium handling and myocardial cell signaling pathways, reducing the strength of heart muscle contractions and thus directly contributing to negative inotropy rather than affecting ECG intervals or ischemic changes.
B: QT prolongation involves delayed ventricular repolarization typically linked to potassium channel dysfunction, unrelated to D3 receptor activity, which primarily affects contractile force rather than electrical repolarization timing.
C: P-R prolongation reflects delayed atrioventricular conduction, mainly influenced by autonomic tone and ion channel modulation, not directly involving D3 receptor-mediated myocardial contractile changes.
D: ST depression is indicative of myocardial ischemia or injury, a pathological ECG finding unrelated to the physiological role of D3 receptors in modulating contractility.
The triad of coma, pinpoint pupil and decreased respiration points toward poisoning with
Rationale:
The triad of coma, pinpoint pupil, and decreased respiration points toward poisoning with Morphine. Morphine, an opioid, causes central nervous system depression, leading to reduced respiratory drive and pinpoint pupils due to parasympathetic dominance. Coma results from severe CNS depression. This classic triad is a hallmark sign in opioid toxicity, distinguishing it from other poisons with different symptoms.
A: Organophosphorus Organophosphorus poisoning primarily causes excessive salivation, sweating, and muscle fasciculations due to cholinergic overstimulation, rather than pinpoint pupils and decreased respiration. Its symptoms differ significantly from the classic opioid triad described.
C: Mushroom Mushroom poisoning symptoms vary widely; some cause hallucinations or gastrointestinal distress rather than pinpoint pupils and respiratory depression. The triad mentioned is not typical for mushroom toxicity presentation.
D: Belladona Belladonna poisoning typically leads to dilated pupils, dry mouth, and agitation due to anticholinergic effects, which contrasts with the pinpoint pupils and depressed respiration seen in morphine poisoning.
The anticholinergic used only as preanesthetic medication is
Rationale:
Glycopyrrolate is the anticholinergic used only as preanesthetic medication. It is preferred because it does not cross the blood-brain barrier, minimizing central nervous system side effects, and effectively reduces salivary and respiratory secretions during anesthesia without causing significant tachycardia or sedation, making it ideal solely for preanesthetic use.
A: Atropine crosses the blood-brain barrier and is used in various clinical settings, including bradycardia and poisoning, not exclusively as a preanesthetic medication, which limits its specificity.
C: Isopropamide is primarily used for gastrointestinal disorders like peptic ulcers, lacking indications for preanesthetic use, thus not fitting the context of exclusively preanesthetic anticholinergic.
D: Dicyclomine mainly treats irritable bowel syndrome by relieving smooth muscle spasms, without application as a preanesthetic drug, so it does not fulfill the question’s criteria.
Which of the following group of analgesic drugs act on the CNS?
Rationale:
Morphine-like drugs act on the central nervous system (CNS) to relieve pain. These opioids bind to specific receptors in the brain and spinal cord, altering pain perception and response. Their central action distinguishes them from drugs that work peripherally. This targeted CNS interaction makes them effective for managing moderate to severe pain by modulating neural pathways directly involved in pain processing.
B: NSAIDs (Aspirin and related drugs) primarily inhibit peripheral enzymes involved in inflammation and pain without significant CNS receptor interaction, targeting pain at its source rather than altering central neural mechanisms.
C: Local anaesthetics block nerve conduction at the site of application, preventing signal transmission, but do not act within the CNS to modulate pain perception.
D: All of the above incorrectly groups drugs with distinct mechanisms; only morphine-like drugs have a direct central nervous system effect among the options provided.
Which of the benzodiazepines is used only as a sedative and hypnotic
Rationale:
Diazepam is used only as a sedative and hypnotic. Diazepam’s pharmacological profile prominently includes sedative and hypnotic effects, making it suitable for inducing sleep and calming anxiety. It lacks significant muscle relaxant or anticonvulsant properties compared to other benzodiazepines, emphasizing its specialized use in sedation and hypnosis within clinical applications.
A: Chlordiazepoxide primarily serves as an anxiolytic and is mainly prescribed for anxiety disorders and alcohol withdrawal, not solely for sedation or hypnotic purposes.
B: Clorazepam functions predominantly as an anxiolytic and muscle relaxant, lacking exclusive use as a sedative or hypnotic agent.
D: Flurazepam is primarily classified as a hypnotic for treating insomnia, but it also has anxiolytic properties, so it is not limited exclusively to sedation and hypnosis.
Blood pressure is thought to generally remain unchanged with which one of the following anaesthetic agent
Rationale:
Blood pressure is thought to generally remain unchanged with Halothane. Halothane maintains cardiac output and systemic vascular resistance relatively stable compared to other agents. It causes minimal alterations in autonomic nervous system activity, resulting in less pronounced hypotensive effects. This stability makes it distinct from enflurane and isoflurane, which typically reduce blood pressure through vasodilation and myocardial depression.
A: Enflurane typically causes a decrease in blood pressure due to vasodilation and negative inotropic effects, making it unlikely to maintain stable blood pressure.
B: Isoflurane often reduces blood pressure by lowering systemic vascular resistance and cardiac contractility, so it does not keep blood pressure unchanged.
C: All of the above is incorrect since enflurane and isoflurane alter blood pressure, unlike halothane, which tends to maintain it.
Flumazenil
Rationale:
Flumazenil can precipitate seizures in mixed overdose. This occurs because flumazenil antagonizes benzodiazepine receptors, potentially reversing protective sedative effects, especially in patients with co-ingestants like tricyclic antidepressants, increasing seizure risk. Its use requires caution due to this severe adverse effect, which limits its routine application in benzodiazepine overdose management, particularly when other drugs are involved.
A: Is cleared renally Flumazenil is primarily metabolized hepatically, not renally, making this statement inaccurate regarding its elimination pathway and pharmacokinetics.
B: Predictably reverses benzodiazepine-induced respiratory depression Respiratory depression reversal by flumazenil is unpredictable, as benzodiazepines rarely cause significant respiratory compromise alone and flumazenil’s effects vary with patient sensitivity.
C: Antagonizes CNS effects of opioids Flumazenil specifically targets benzodiazepine receptors; it does not antagonize opioid receptors or counteract opioid-induced CNS depression, which requires naloxone for reversal.
Regarding local anaesthetics (LA), which statement is true?
Rationale:
Lignocaine’s half-life may be increased 3-4 fold in patients with severe liver disease. This occurs because lignocaine is primarily metabolised by hepatic enzymes, and impaired liver function slows its clearance, prolonging its systemic presence and effects. Severe hepatic impairment significantly reduces metabolic capacity, causing accumulation and extended duration of action, which necessitates careful dose adjustments in these patients.
A: Lignocaine is metabolised in the liver, but it is not the fastest among amide LAs; other amides like prilocaine have quicker hepatic metabolism, making this statement inaccurate.
B: Allergies to amide LAs are rare overall, but ester LAs have a higher incidence of allergic reactions due to their metabolism producing para-aminobenzoic acid.
C: Prilocaine is associated with methemoglobinemia, not cardiotoxicity; bupivacaine is known for being the most cardiotoxic local anaesthetic, refuting this assertion.
A group of teenage boys comes to the emergency department after ingesting a plant they heard would make them high. One member of the group still had some plant parts in his pocket, which you use to identify deadly nightshade that contains compounds metabolized to atropine. Which of the following is an effect of atropine?
Rationale:
Mydriasis is an effect of atropine. Atropine is an anticholinergic agent that blocks muscarinic receptors, leading to pupil dilation by inhibiting the parasympathetic stimulation of the sphincter pupillae muscle. This results in unopposed sympathetic activity, causing the pupils to dilate, which is a characteristic sign following atropine exposure from deadly nightshade ingestion.
A: Bronchospasm Atropine causes bronchodilation by blocking parasympathetic input to airway smooth muscle, so bronchospasm does not occur. It relaxes bronchial muscles rather than constricting them.
B: Lacrimation Atropine inhibits parasympathetic stimulation, reducing tear production. It leads to dry eyes instead of increased lacrimation, which contradicts this option.
D: Salivation Atropine decreases salivary secretion by blocking muscarinic receptors, causing dry mouth rather than excessive salivation, making this option inaccurate.
In review of the benzodiazepine class, which of the following agents has the longest duration of action and may be useful in the treatment of a 39-year-old patient with spinal cord injury and with skeletal muscle spasticity?
Rationale:
Diazepam has the longest duration of action among the benzodiazepines listed and is effective for treating skeletal muscle spasticity in patients with spinal cord injury. Diazepam’s long half-life and active metabolites provide sustained muscle relaxation, making it suitable for managing chronic spasticity, unlike shorter-acting benzodiazepines that may require more frequent dosing and have less consistent effects.
B: Lorazepam has a shorter half-life and lacks active metabolites, resulting in a shorter duration of action, making it less suitable for long-term muscle spasticity management compared to diazepam.
C: Oxazepam is primarily used for anxiety and has a relatively short duration of action, limiting its utility in treating muscle spasticity in spinal cord injury patients.
D: Temazepam is mainly prescribed for insomnia due to its intermediate duration of action and does not provide the prolonged muscle relaxation needed for spasticity treatment.
A 47-year-old man with seizure disorder presents to his primary care physician for follow-up. Because of a recent exacerbation in his seizures, he is prescribed with lacosamide. Which of the following is the most likely mechanism of action of this medication?
Rationale:
Lacosamide exerts its antiepileptic effect primarily through blockade of sodium channels. This action stabilizes hyperexcitable neuronal membranes and inhibits repetitive neuronal firing by enhancing slow inactivation of voltage-gated sodium channels. This mechanism reduces seizure activity by preventing the rapid, abnormal electrical discharges characteristic of epilepsy, differentiating lacosamide from drugs targeting other pathways or receptors.
A: Binds to collapsing response mediator protein-2 This mechanism is associated with lacosamide’s binding but is not the primary antiepileptic action; it modulates neuronal growth rather than controlling excitability directly.
B: Binds to GABA receptors GABA receptor binding typically enhances inhibitory neurotransmission, but lacosamide does not act by modulating GABAergic pathways, distinguishing it from benzodiazepines or barbiturates.
C: Blockade of calcium channels Calcium channel blockade is a mechanism of drugs like ethosuximide, not lacosamide, which primarily targets sodium channels to reduce neuronal excitability and seizure propagation.
A 64-year-old man presents with a shuffling gait, cogwheel rigidity, and a resting tremor. His physician prescribes levodopa and his symptoms greatly improve, supporting a diagnosis of Parkinson's disease. How does levodopa help this patient's symptoms?
Rationale:
Levodopa helps this patient's symptoms by increasing dopamine production. It acts as a precursor to dopamine, crossing the blood-brain barrier and replenishing diminished dopamine levels in the basal ganglia, which alleviates motor symptoms such as rigidity, tremor, and bradykinesia characteristic of Parkinson's disease.
B: Inhibit acetylcholinesterase Acetylcholinesterase inhibitors primarily increase acetylcholine levels and are used in conditions like Alzheimer's disease, not Parkinson's, so they do not address dopamine deficiency causing this patient's symptoms.
C: Stimulate acetylcholine receptors Stimulating acetylcholine receptors would worsen Parkinsonian symptoms by increasing cholinergic activity, which opposes dopamine effects, making this approach unsuitable for treating Parkinson’s disease.
D: Stimulate dopamine receptors Dopamine receptor stimulation occurs with dopamine agonists, not levodopa, which increases dopamine synthesis. Levodopa’s mechanism involves dopamine production, not direct receptor stimulation.
A 66-year-old woman who has smoked two packs of cigarettes per day for 50 years has chronic bronchitis. She has tried to quit five times in the past but felt she could not go long without a cigarette. The nicotine in her cigarettes stimulates many cells in her body by binding certain receptors. Which of the following drugs blocks nicotinic receptors?
Rationale:
Hexamethonium blocks nicotinic receptors by acting as a ganglionic blocker, preventing nicotine from stimulating autonomic ganglia. It specifically inhibits transmission at nicotinic acetylcholine receptors located in the autonomic nervous system, thereby counteracting nicotine’s effects on these receptors, unlike other drugs that act on muscarinic or adrenergic receptors.
A: Atropine targets muscarinic acetylcholine receptors, not nicotinic receptors, so it does not block the action of nicotine on nicotinic receptors.
B: Bethanechol stimulates muscarinic receptors, promoting parasympathetic activity, and does not antagonize nicotinic receptors.
D: Metoprolol selectively blocks beta-1 adrenergic receptors, unrelated to nicotinic receptor activity or nicotine’s mechanism.
A 43-year-old man who is a heroin addict is placed on methadone therapy to wean him off of heroin. Which of the following statements is true regarding the pharmacology of this agent?
Rationale:
Methadone is biotransformed in the liver and excreted in urine. This reflects its hepatic metabolism primarily via cytochrome P450 enzymes, followed by renal elimination of metabolites, making option B accurate. The liver’s role in methadone processing is crucial for its pharmacokinetics and dosing considerations during opioid substitution therapy.
A: Best absorbed following intravenous administration does not apply because methadone is well absorbed orally, which is preferred for maintenance therapy.
C: Lipophilic causing accumulation in tissues is misleading; although methadone is lipophilic, its clinical relevance centers on hepatic metabolism rather than tissue accumulation.
D: Metabolism dependent in single cytochromes in the liver is inaccurate; methadone metabolism involves multiple cytochrome P450 isoforms, not a single enzyme system.
Aspirin is used in treatment of:
Rationale:
Aspirin is used in treatment of acute rheumatic fever. Aspirin’s anti-inflammatory and antipyretic properties make it effective in managing acute rheumatic fever symptoms, reducing inflammation and fever associated with this autoimmune condition following streptococcal infection. It helps alleviate joint pain and inflammation, which are hallmark features of acute rheumatic fever, thereby improving patient outcomes and comfort during the disease course.
A: Vertigo Aspirin does not address the neurological or vestibular dysfunctions causing vertigo and lacks efficacy in treating balance or dizziness-related symptoms. Its pharmacological actions target inflammation and pain rather than inner ear disorders.
B: Peptic ulcer Aspirin can exacerbate peptic ulcers by irritating the gastric mucosa and inhibiting protective prostaglandins, making it unsuitable and potentially harmful for peptic ulcer treatment or management.
C: Acute bronchial asthma Aspirin may precipitate asthma attacks in sensitive individuals due to its effect on leukotriene pathways, thus contraindicating its use in acute bronchial asthma treatment and symptom control.
The following statements are correct about MAO inhibitors EXCEPT:
Rationale:
Combination of a MAO-inhibitor and a selective serotonin reuptake inhibitor produces a synergistic effect useful in treatment of depression. This statement is incorrect because combining these drugs risks serotonin syndrome, a dangerous condition, rather than providing a safe, synergistic antidepressant effect. Careful management is required to avoid severe adverse interactions.
A: Combination of old cheese or beer with MAO inhibitors can cause hypertensive crisis This is true due to tyramine in these foods causing excessive norepinephrine release, dangerously elevating blood pressure when MAO is inhibited.
B: Selegiline (deprenyl) is a selective MAO (B) inhibitor This is accurate; selegiline preferentially inhibits MAO-B, primarily affecting dopamine metabolism and used in Parkinson's disease and depression treatment.
D: MAO-inhibitors reduce oxidative deamination of noradrenaline, serotonin & dopamine This statement correctly describes the mechanism of MAO inhibitors, which block enzymatic breakdown of these neurotransmitters, increasing their synaptic availability.
Narcotic analgesics include which of the following:
Rationale:
Narcotic analgesics include Codeine. Codeine is an opioid derived from the opium poppy and acts on the central nervous system to relieve pain. It is classified as a narcotic analgesic because it produces sedation and alters pain perception, distinguishing it from non-narcotic analgesics which do not share these opioid properties or central nervous system effects.
A: Aspirin Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that reduces pain by inhibiting prostaglandin synthesis, lacking the central nervous system effects and opioid properties characteristic of narcotic analgesics.
B: Papaverine Papaverine is an antispasmodic agent that relaxes smooth muscle but does not have analgesic or narcotic qualities, thus it does not function as a narcotic analgesic.
D: Indomethacin Indomethacin is an NSAID primarily used to reduce inflammation and pain by blocking cyclooxygenase enzymes, without narcotic or opioid-like actions associated with narcotic analgesics.
A patient with severe schizophrenia started therapy with clozapine. Which of the following is the most serious adverse response associated with this drug?
Rationale:
C: Serious infection due to agranulocytosis is the most serious adverse response associated with clozapine. Clozapine can cause a dangerous drop in white blood cells (agranulocytosis), leading to life-threatening infections. This risk mandates regular blood monitoring. Its severity surpasses other side effects, making it a critical safety concern during clozapine therapy for schizophrenia.
A: Bronchoconstriction involves airway narrowing typically linked to asthma or allergic reactions, not commonly triggered by clozapine. This adverse effect is unrelated to clozapine’s pharmacological profile or its known serious toxicities.
B: Seizures can occur with clozapine but are less severe compared to agranulocytosis. Seizures represent a dose-dependent risk rather than an immediately life-threatening hematological condition.
D: Tardive dyskinesia is a long-term movement disorder mainly associated with typical antipsychotics, whereas clozapine has a lower risk of causing this extrapyramidal side effect.
The following opiate drugs are paired correctly with their pharmacological class, EXCEPT:
Rationale:
Heroin----- agonist is the incorrect pairing.
Heroin is an opioid agonist, meaning it activates opioid receptors, not mixed agonist/antagonist. The question asks for the incorrect pair. Dextromethorphan and Butorphanol are mixed agonist/antagonists because they both activate and block different opioid receptors. Naloxone is a pure antagonist, blocking opioid receptors without activation.
B: Dextromethorphan--- mixed agonist/antagonist accurately describes its dual role, modulating multiple receptor types, making this pairing correct and consistent with pharmacological classifications.
C: Naloxone----- antagonist correctly identifies it as a pure antagonist that reverses opioid effects by competitively inhibiting opioid receptors without any agonist activity.
D: Butorphanol----- mixed agonist/antagonist properly reflects its pharmacology, acting as an agonist at some opioid receptors and antagonist at others, fitting the mixed classification precisely.
A 5-year-old child is admitted to the hospital with low grade fever and a persistent cough. His throat culture is negative, his fever has resolved, and all that is left is slight cough. Which of the following is an OTC opioid antitussive could the paediatrician recommend for this child?
Rationale:
Dextromethorphan is an OTC opioid antitussive suitable for children with a persistent cough after other symptoms have resolved. It acts centrally to suppress the cough reflex without significant opioid effects or sedation, making it safe and effective for pediatric use in minor respiratory conditions.
A: Tramadol Primarily functions as a prescription analgesic with opioid properties, not recommended as an OTC cough suppressant due to its potency and risk of adverse effects in children.
B: Propoxyphene Withdrawn in many countries because of safety concerns and is not indicated for cough suppression, especially in pediatric patients.
C: Loperamide An opioid derivative used to treat diarrhea by slowing gut motility, not effective or appropriate as an antitussive agent in children.
Propylthiouracil can produce:
Rationale:
Propylthiouracil inhibits the conversion of T4 to T3. This drug specifically blocks the enzyme 5'-deiodinase, which converts thyroxine (T4) into the more active triiodothyronine (T3), thereby reducing thyroid hormone activity and alleviating hyperthyroid symptoms, distinguishing it from other antithyroid medications that primarily inhibit hormone synthesis rather than peripheral conversion.
A: Inhibit iodine uptake does not describe propylthiouracil’s action; this effect is characteristic of substances like perchlorate or thiocyanate, which competitively block iodine transport into thyroid cells.
C: Decrease size of goiter is not a primary effect of propylthiouracil; goiter size reduction typically occurs through long-term hormone level normalization, not direct pharmacologic action.
D: Decrease exophthalmos does not occur with propylthiouracil; exophthalmos relates to autoimmune inflammation, which requires different treatments targeting immune modulation rather than thyroid hormone inhibition.
In hypothyroidism, T4 is more commonly prescribed as a supplement than T3 because:
Rationale:
T4 is more commonly prescribed as a supplement in hypothyroidism because some of the T4 is converted, in the body, to T3. This conversion allows the body to regulate T3 levels naturally, providing a stable and controlled thyroid hormone effect. T4’s longer half-life also ensures consistent hormone availability, making it the preferred therapeutic choice.
A: Hypothyroidism does not specifically involve only T4 deficiency; both T4 and T3 levels can be affected. T3 levels often decrease, making this option an oversimplification and inaccurate representation of thyroid hormone dynamics.
C: T3 has a rapid onset of action, not slow. Its effects appear quickly because it is the active form of thyroid hormone, ruling out this option based on pharmacokinetic properties.
D: T3 certainly has significant physiologic and pharmacologic effects as the active thyroid hormone form. Its biological activity is well-established, invalidating the claim that it lacks these effects.
Which of the following is the most common adverse effect of metformin?
Rationale:
Metformin most commonly causes gastrointestinal (GI) effects as an adverse reaction.
Metformin often leads to GI symptoms such as nausea, diarrhea, and abdominal discomfort due to its action on the gut and alteration of glucose absorption. These effects are frequent and usually transient, making GI disturbances the predominant side effect reported in clinical use and patient experiences with metformin therapy.
A: Hypoglycemia Metformin rarely induces hypoglycemia because it does not increase insulin secretion, unlike other antidiabetic drugs. Its mechanism primarily reduces hepatic glucose production without causing low blood sugar.
B: Hyperinsulinemia Metformin does not cause hyperinsulinemia since it enhances insulin sensitivity and decreases hepatic glucose output without stimulating excess insulin secretion.
D: Pruritus Pruritus is not commonly associated with metformin use and is an uncommon side effect, lacking a direct mechanistic link to metformin’s pharmacological action.
The unique property of SERMs is that they:
Rationale:
SERMs act as agonists in some tissues and antagonists in other tissues. This selective mechanism allows them to mimic estrogen’s effects where beneficial while blocking estrogen action in tissues where it may promote disease, such as breast tissue in cancer therapy. Their dual activity differentiates them from agents that uniformly activate or inhibit estrogen pathways.
B: Activate a unique plasma membrane-bound receptor describes non-SERM mechanisms involving membrane estrogen receptors, not the tissue-specific agonist/antagonist action characteristic of SERMs. This does not capture their selective receptor modulation.
C: Have both estrogenic and progestational agonist activity inaccurately combines hormone activities; SERMs selectively modulate estrogen receptors without significant progestational receptor activation, distinguishing them from combined hormone therapies.
D: Inhibit the aromatase enzyme required for estrogen synthesis refers to aromatase inhibitors, which reduce estrogen production, unlike SERMs that modulate estrogen receptor responses without affecting hormone synthesis.
Flumazenil
Rationale:
Flumazenil can precipitate seizures in mixed overdose. This is because flumazenil is a benzodiazepine receptor antagonist that reverses sedation but may provoke withdrawal seizures, especially in patients with chronic benzodiazepine use or co-ingestion of proconvulsant drugs. Its use requires caution in mixed overdoses due to the risk of inducing life-threatening seizures as a consequence of abrupt benzodiazepine antagonism.
A: Is cleared renally Flumazenil is primarily metabolized hepatically, not renally, so renal clearance does not significantly contribute to its elimination or influence dosing adjustments in renal impairment.
B: Predictably reverses benzodiazepine-induced respiratory depression Flumazenil’s reversal of respiratory depression is inconsistent and unpredictable, as it may not reliably restore ventilation, especially in mixed overdoses or chronic benzodiazepine users.
C: Antagonizes CNS effects of opioids Flumazenil specifically targets benzodiazepine receptors and has no antagonistic activity on opioid receptors, thus it does not reverse opioid-induced central nervous system effects.
Regarding local anaesthetics (LA), which statement is true?
Rationale:
Lignocaine's half-life may be increased 3-4 fold in a patient with severe liver disease. This occurs because lignocaine is extensively metabolized by hepatic enzymes, and impaired liver function reduces drug clearance, leading to prolonged systemic circulation time and increased potential for toxicity. Liver disease significantly impacts the pharmacokinetics of lignocaine, necessitating dose adjustments.
A: Lignocaine is not metabolized faster than all other amide LAs; its metabolism rate is moderate and depends on hepatic enzyme activity rather than being the fastest.
B: Allergies to ester LAs are more common due to their metabolite para-aminobenzoic acid, making amide LA allergies comparatively rare.
C: Prilocaine is less cardiotoxic than bupivacaine; bupivacaine holds the highest cardiotoxic potential among commonly used local anesthetics.
A group of teenage boys comes to the emergency department after ingesting a plant they heard would make them high. One member of the group still had some plant parts in his pocket, which you use to identify deadly nightshade that contains compounds metabolized to atropine. Which of the following is an effect of atropine?
Rationale:
Atropine causes mydriasis.
Atropine is an anticholinergic agent that blocks muscarinic receptors, leading to pupil dilation or mydriasis by inhibiting the parasympathetic constriction of the iris sphincter muscle. This effect helps differentiate atropine poisoning from other conditions, as it reduces parasympathetic activity and results in characteristic symptoms like dry mouth, tachycardia, and blurred vision.
A: Bronchospasm Bronchospasm involves airway constriction, typically mediated by parasympathetic stimulation, but atropine’s anticholinergic effect causes bronchodilation, not bronchospasm.
B: Lacrimation Lacrimation is increased tear production linked to parasympathetic activation; atropine blocks this pathway, causing decreased tearing instead of increased lacrimation.
D: Salivation Salivation is stimulated by parasympathetic input; atropine inhibits this, resulting in dry mouth rather than increased salivation.
In review of the benzodiazepine class, which of the following agents has the longest duration of action and may be useful in the treatment of a 39-year-old patient with spinal cord injury and with skeletal muscle spasticity?
Rationale:
Diazepam has the longest duration of action among the benzodiazepines listed and is effective for treating skeletal muscle spasticity in patients with spinal cord injury. Diazepam’s prolonged half-life allows for sustained muscle relaxation, making it suitable for chronic management. Its active metabolites contribute to extended effects, providing consistent symptom control without frequent dosing, which is critical in spasticity treatment.
B: Lorazepam has a shorter duration and lacks active metabolites, limiting its effectiveness for prolonged muscle spasticity relief. Its primary use is anxiety and seizure management, not long-term spasticity treatment.
C: Oxazepam is a short-acting benzodiazepine primarily used for anxiety and alcohol withdrawal, not for muscle spasticity, and has no significant muscle relaxant properties relevant to this context.
D: Temazepam is mainly prescribed for insomnia due to its intermediate duration, without significant muscle relaxant effects, making it unsuitable for managing chronic skeletal muscle spasticity.
A 47-year-old man with seizure disorder presents to his primary care physician for follow-up. Because of a recent exacerbation in his seizures, he is prescribed with lacosamide. Which of the following is the most likely mechanism of action of this medication?
Rationale:
Lacosamide works by blockade of sodium channels. This antiepileptic drug selectively enhances slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing, thereby reducing seizure activity. Its unique mechanism distinguishes it from other sodium channel blockers by specifically targeting slow inactivation without affecting fast inactivation, contributing to its efficacy and tolerability in seizure management.
A: Binds to collapsing response mediator protein-2 This mechanism is associated with axonal outgrowth and neuronal development, unrelated to lacosamide’s antiepileptic action, which focuses on modulating ion channel function rather than cytoskeletal dynamics.
B: Binds to GABA receptors GABA receptor binding enhances inhibitory neurotransmission, typical of benzodiazepines and barbiturates, but lacosamide does not exert its effect through GABAergic pathways or modulation of inhibitory synaptic activity.
C: Blockade of calcium channels Calcium channel blockade reduces neurotransmitter release in some antiepileptics like ethosuximide, but lacosamide primarily targets sodium channels, making calcium channel inhibition irrelevant to its anticonvulsant mechanism.
A 64-year-old man presents with a shuffling gait, cogwheel rigidity, and a resting tremor. His physician prescribes levodopa and his symptoms greatly improve, supporting a diagnosis of Parkinson's disease. How does levodopa help this patient's symptoms?
Rationale:
Levodopa helps this patient's symptoms by increasing dopamine production. Parkinson's disease involves dopaminergic neuron loss, reducing dopamine in the basal ganglia. Levodopa, a dopamine precursor, crosses the blood-brain barrier and converts to dopamine, replenishing depleted levels. This restoration improves motor symptoms like rigidity, tremor, and bradykinesia by enhancing dopaminergic signaling in affected brain regions.
B: Inhibit acetylcholinesterase This option relates to increasing acetylcholine by preventing its breakdown, often used in Alzheimer's treatment, not Parkinson's, and does not address dopamine deficiency causing the patient's symptoms.
C: Stimulate acetylcholine receptors Activating acetylcholine receptors would exacerbate motor issues in Parkinson's, as the disease involves dopaminergic loss, not cholinergic receptor underactivity, making this mechanism unrelated to symptom improvement.
D: Stimulate dopamine receptors Direct stimulation of dopamine receptors occurs with dopamine agonists, but levodopa works by increasing dopamine synthesis, not direct receptor activation, differentiating its pharmacological action from this choice.